版本:
中国

BRIEF-Valeant announces pricing for Siliq

April 21 Valeant Pharmaceuticals International Inc

* Valeant's patient access and pricing committee announces pricing for Siliq(brodalumab) as the lowest priced injectable biologic for moderate-to-severe plaque psoriasis

* Valeant - sales and marketing of Siliq are expected to commence in U.S. During second half of 2017

* Valeant - decided to list Siliq injection, at $3,500 per month

* Valeant - Siliq will also be included in company's patient access program to further offer financial support and access to patients Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐